Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism

2013910 citationsJournal Articlebronze Open Access

Authors

Bernhard Meier · University Hospital of Bern

Bindu Kalesan · University Hospital of Bern

Heinrich P. Mattle · University Hospital of Bern

Ahmed A. Khattab · University Hospital of Bern

David Hildick‐Smith

Dariusz Dudek · Jagiellonian University

Grethe Andersen · Aarhus University Hospital

Abstract

Closure of a patent foramen ovale for secondary prevention of cryptogenic embolism did not result in a significant reduction in the risk of recurrent embolic events or death as compared with medical therapy. (Funded by St. Jude Medical; ClinicalTrials.gov number, NCT00166257.).

Topics & Keywords

Cardiovascular and Diving-Related Complications Traumatic Brain Injury and Neurovascular Disturbances Takotsubo Cardiomyopathy and Associated Phenomena

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 368, Issue 12, pp. 1083-1091

DOI: 10.1056/nejmoa1211716

Field-Weighted Citation Impact: 77.92